Keratosis Follicularis Spinulosa Decalvans – KFSD
Keratosis follicularis spinulosa decalvans (KFSD) is a rare inherited skin disorder belonging to the keratosis pilaris atrophicans (KPA) group. It causes spiny keratotic papules at the hair follicles that progress to skin atrophy and permanent scarring hair loss (cicatricial alopecia) of the scalp, eyebrows and eyelashes, and it is often accompanied by significant eye problems.
Advances in molecular biology and genetics have clarified how KFSD develops:
- MBTPS2 mutations and X-linked inheritance: KFSD is mostly inherited in an X-linked dominant pattern (a few cases are autosomal recessive or autosomal dominant). It is caused by mutations in the MBTPS2 gene, which encodes membrane-bound transcription factor peptidase, site 2, located on the short arm of the X chromosome (Xp22.12/Xp22.11).
- Defective regulated intramembrane proteolysis (RIP): MBTPS2 is a zinc metalloprotease that cleaves key transcription factors such as SREBP (which controls lipid and cholesterol synthesis) and ATF6 (which controls the endoplasmic reticulum stress response). Loss of MBTPS2 function disrupts the differentiation of skin cells (keratinocytes), reduces membrane lipid production and sets off a cascade of cellular stress.
- Excess keratinization and follicle damage: Abnormal keratinization produces spiny keratotic plugs lodged deep in the follicular infundibulum. These plugs block and rupture the follicle wall, drawing in an inflammatory infiltrate of macrophages and lymphocytes.
- Stem cell loss and permanent fibrosis: Persistent chronic inflammation around the upper follicle gradually destroys the bulge region, where follicular stem cells live. The skin thins and the follicle is replaced entirely by fibrotic scar tissue.
Because KFSD is a genetic condition that progresses from childhood, Haute-Derma focuses on early genetic diagnosis and coordinated care across dermatology, ophthalmology and medical genetics, aiming to slow follicular scarring and protect the patient's vision.
Clinical Features and Differential Diagnosis
KFSD typically presents with a triad of spiny follicular keratosis, progressive scarring alopecia and light-sensitive eye problems:
- Onset in Childhood: Symptoms often begin in the first few months of life or early childhood, as spiny follicular keratosis on the face, scalp and trunk.
- Spiny Follicular Papules:
- Small, firm, red or skin-colored papules, each with a sharp keratin spike (horny spine) projecting from the center.
- The scalp, cheeks, neck or limbs feel rough, like a washboard.
- Progressive Scarring Alopecia and Skin Atrophy:
- Scalp hair gradually thins and gives way to smooth, shiny, atrophic scarred patches with no follicular openings left.
- Loss of eyebrows and eyelashes (madarosis): Loss starts in the outer third and extends to the entire brow and lash line, leaving a band of thinned, reddened skin.
- Net-like facial atrophoderma, especially on the cheeks and forehead.
- Characteristic Eye Involvement (Screening Is Essential):
- Severe photophobia: A very typical eye symptom of KFSD; affected children constantly squint or avoid sunlight.
- Conjunctivitis, chronic blepharitis, corneal dystrophy or epithelial erosions, which can lead to corneal clouding and reduced vision.
- Trichoscopy Findings:
- Raised gray-yellow spiny keratin plugs filling the follicular openings.
- Complete absence of follicular openings in scarred areas.
- Redness and ivory-white atrophic patches around the remaining follicles.
How Haute-Derma Diagnoses and Treats KFSD
- Multidisciplinary Diagnostic Workup:
- Scalp biopsy (4 mm punch): Shows follicular hyperkeratosis, thick keratin plugs in the infundibulum, a lymphocytic/macrophage infiltrate around the follicles, atrophy of the sebaceous glands and bands of dermal fibrosis.
- Genetic testing: Sequencing of the MBTPS2 gene pinpoints the mutation, confirms the diagnosis and supports genetic counseling for the family.
- Ophthalmology consultation: The ocular surface is assessed, with slit-lamp examination for corneal erosions or clouding, so problems can be treated promptly.
- Controlling Disease Activity and Symptoms:
- Oral retinoids (acitretin / isotretinoin): The main systemic treatment. Retinoids normalize epidermal keratinization, soften and reduce follicular spines, and in turn calm inflammation around the follicles.
- Keratolytics and intensive moisturizers: Products containing urea (10–20%), salicylic acid (2–5%), lactic acid or ammonium lactate soften and loosen the surface keratin spines.
- Low- to mid-potency topical corticosteroids or calcineurin inhibitors (tacrolimus 0.1%): Applied intermittently to the scalp and eyebrows to settle acute inflammation without worsening skin atrophy.
- Eye care and protection: Preservative-free artificial tears, a lubricating eye gel at night and UV-blocking sunglasses ease photophobia and protect the cornea.
